Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Arun J. Sanyal, Lee M. Kaplan, Juan P. Frias et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
Arun J. Sanyal, Lee M. Kaplan, Juan P. Frias et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
David B. Antcliffe, Katie L. Burnham, Farah Al-Beidh et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · Randomised trial
Full textCC BY